Jeffrey Skinner

Nessuna posizione attualmente

Patrimonio netto: 175 269 $ in data 31/03/2024

Health Technology

Consumer Services

Profilo

Jeffrey Skinner worked as the Director of Business Development at SteriMax, Inc. from 2012 to 2014.
He then worked as the Vice President of Business Development at ChitogenX, Inc. After that, he worked as the Vice President of Business Development at Valeo Pharma, Inc. from 2014 to 2023.
Mr. Skinner received his undergraduate degree and MBA from the University of Western Ontario in 1997 and 1999, respectively.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
VALEO PHARMA INC CLASS A 1.42%	15/03/2023	1 402 150 ( 1.42% )	175 269 $	31/03/2024

Precedenti posizioni note di Jeffrey Skinner

Società	Posizione	Fine
VALEO PHARMA INC.	Corporate Officer/Principal	01/07/2023
SteriMax, Inc. SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada.	Corporate Officer/Principal	01/07/2014
CHITOGENX INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Jeffrey Skinner

Formazione di Jeffrey Skinner

University of Western Ontario

Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jeffrey Skinner

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
CHITOGENX INC.	Health Technology
VALEO PHARMA INC.	Health Technology

Aziende private	1
SteriMax, Inc. SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada.	Health Technology